连接体和残留物自由能量扰乱解决了A2BAR部分激动剂的双结模式建议
Tana Tandarić1, Hugo Gutiérrez-de-Terán1,2
1Department of Cell and Molecular Biology, Biomedical Center, Uppsala University, Box 596, Uppsala SE-75124, Sweden.
计算模拟澄清了部分激动剂BAY60-6583与腺A2B受体 (A2B AR) 的结合模式. 这一发现有助于设计改进的A2B AR向治疗方法,用于诸如癌症免疫疗法等疾病.
科学领域:
- 药理学 药理学是指药理学的学科.
- 结构生物学 结构生物学
- 计算化学的计算化学
背景情况:
- 氨酸A2B受体 (A2B AR) 是一种治疗点,特别是在癌症免疫治疗中.
- 有选择性的A2BAR抗剂可用,但缺乏选择性的全激动剂.
- BAY60-6583是一种关键的部分激动剂,但其与A2B AR的结合性取向仍在争论中.
研究的目的:
- 为了确定部分激动剂BAY60-6583对A2B AR的生理相关结合模式.
- 将计算预测与实验性突变发生数据进行比较.
- 为了指导基于结构的新型A2B AR调制器的设计.
主要方法:
- 使用QligFEP和QresFEP计算协议来计算具有约束力的自由能量转移.
- 对比BAY60-6583的结合亲和力在不同的结合位置.
- 在基突变性研究中进行并与实验数据进行比较.
主要成果:
- 计算模拟对BAY60-6583.3的单一,实验支持的绑定模式进行了融合.
- 验证的结合模式准确地解释了现有的结构-活性关系 (SAR) 和突变发生的数据.
- 自由能量扰动方法在基于结构的药物设计中被证明是有价值的.
结论:
- 这项研究阐明了BAY60-6583对A2B AR.的正确结合方向.
- 这种验证的结合模式作为设计改进的A2B AR部分激动剂的基础.
- 强调了计算自由能源方法在药物发现中的实用性.
更多相关视频
07:16Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission
Published on: August 16, 2018
07:41A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators
Published on: February 20, 2018
相关概念视频
The Two-State Receptor Model
The binding affinity of a drug determines its interaction with...
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
Drug-Receptor Interaction: Agonist
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Drug-Receptor Interactions
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
Ligand Binding and Linkage
Ligand-Gated Ion Channel Receptor: Gating Mechanism
